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Comparison of protein expression during wild-type, and E1B-
55k-deletion, adenovirus infection using quantitative time-
course proteomics
Yen Rong Fu,1 Andrew S. Turnell,2 Simon Davis,2 Kate J. Heesom,3 Vanessa C. Evans1 and David A. Matthews1,*
Abstract
Adenovirus has evolved strategies to usurp host-cell factors and machinery to facilitate its life cycle, including cell entry,
replication, assembly and egress. Adenovirus continues, therefore, to be an important model system for investigating
fundamental cellular processes. The role of adenovirus E1B-55k in targeting host-cell proteins that possess antiviral activity
for proteasomal degradation is now well established. To expand our understanding of E1B-55k in regulating the levels of
host-cell proteins, we performed comparative proteome analysis of wild-type, and E1B-55k-deletion, adenovirus-infected
cancer cells. As such we performed quantitative MS/MS analysis to monitor protein expression changes affected by viral
E1B-55k. We identified 5937 proteins, and of these, 69 and 58 proteins were down-regulated during wild-type and E1B-55k
(dl1520) adenovirus infection, respectively. This analysis revealed that there are many, previously unidentified, cellular
proteins subjected to degradation by adenovirus utilizing pathways independent of E1B-55k expression. Moreover, we found
that ALCAM, EPHA2 and PTPRF, three cellular proteins that function in the regulation of cell–cell contacts, appeared to be
degraded by E1B-55k/E4orf3 and/or E1B-55k/E4orf6 complexes. These molecules, like integrin a3 (a known substrate of
E1B-55k/E4orf6), are critical regulators of cell signalling, cell adhesion and cell surface modulation, and their degradation
during infection is, potentially, pertinent to adenovirus propagation. The data presented in this study illustrate the broad
nature of protein down-regulation mediated by adenovirus.
INTRODUCTION
Adenoviruses are non-enveloped, icosahedral particles con-
taining a linear double-stranded DNA (dsDNA) genome
that is approximately 36 kbp in size. Adenovirus (Ad) was
originally isolated from human adenoids in tissue culture in
1953 [1] and since then has been widely studied as a model
viral system and as a powerful tool for uncovering funda-
mental cellular processes from cell-cycle control to splicing
[2–4]. As part of its wide-ranging effects in the infected cell,
adenovirus triggers virally induced degradation of cellular
proteins to facilitate its own replication. Through early
region 1A and 1B (E1A and E1B) and E4 proteins it has
been known for some time that adenovirus induces the spe-
cific degradation of host-cell proteins to favour viral replica-
tion [5, 6]. A well-understood target is the cellular DNA
damage response (DDR), principally the Mre11-Rad50-
Nbs1 (MRN) complex, which would normally be triggered
as the viral linear dsDNA genome builds up in the cell,
mimicking extensive dsDNA breaks in the host-cell genome
[7]. To counteract this, the adenoviral E1B-55k/E4orf6 pro-
teins cooperate to redirect a cullin-containing ubiquitin
ligase to specifically target a key component of the DDR
known as MRE11. This consequently inhibits activation of
the protein kinases ATM and ATR (reviewed in [8]). Other
substrates of the E1B-55k/E4orf6 complex that are indepen-
dent of MRN and play a major role in the host-cell intrinsic
defence mechanism against adenovirus include p53, DNA
ligase IV, integrin a3, Bloom helicase, DAXX/ATRX, Tip60
and SPOC1 [9–15].
The adenovirus E4orf3 protein is also critical for inducing
specific degradation of host proteins. Following infection,
this viral protein reorganizes promyelocytic leukaemia
(PML) nuclear bodies into distinctive track-like structures
in the nucleus, where it then transiently binds to E1B-55k
Received 4 January 2017; Accepted 18 March 2017
Author affiliations:
1School of Cellular and Molecular Medicine, University Walk, University of Bristol, Bristol BS8 1TD, UK; 2Institute of Cancer and
Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK; 3Proteomics Facility,
Faculty of Biomedical Sciences, University Walk, University of Bristol, Bristol BS8 1TD, UK.
*Correspondence: David A. Matthews, d.a.matthews@bristol.ac.uk
Keywords: adenovirus; d11520; E1B-55k; proteomics.
Abbreviations: Ad, adenovirus; DDR, DNA damage response; E1A, early region 1A; E1B, early region 1B; MRN, Mre11-Rad50-Nbs1 complex; MS/MS,
tandem mass spectrometry; TMT, tandem mass tagging.
Two supplementary tables are available with the online Supplementary Material.
RESEARCH ARTICLE
Fu et al., Journal of General Virology 2017;98:1377–1388
DOI 10.1099/jgv.0.000781
000781 ã 2017 The Authors
This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/, which permits unrestricted use, distribution and reproduction in any medium, provided the original
author and source are credited.
1377
Downloaded from www.microbiologyresearch.org by
IP:  137.222.138.50
On: Tue, 22 Aug 2017 07:58:10
[16, 17]. It is thought that E4orf3 sequesters MRN compo-
nents into these tracks and forms a complex with E1B-55k
and E4orf6 in order to transport MRN to cytoplasmic aggre-
somes for the degradation of MRE11 [18, 19]. Even in the
absence of E1B-55K and E4orf6, the relocalization of MRN
to nuclear tracks by E4orf3 alone is enough to inactivate the
DDR [20]. In fact, it has been shown that E4orf3 can inde-
pendently utilize the ubiquitin–proteasome pathway to pro-
mote the degradation of transcriptional intermediary factor
1g (TIF1g) [21]. An additional cellular substrate of E4orf3
has recently been identified; the general transcription factor
II–I (GTF2I) is targeted by E4orf3 for ubiquitination and
proteasomal degradation, which stimulates gene expression
from a GTF2I-repressed viral promoter [22].
Allied to these observations, genetically modified adeno-
viruses that are deleted for one or more viral early gene(s)
have been developed for experimental and clinical purposes
(reviewed in [23, 24]). An adenovirus deletion mutant called
dl1520 (also known as ONYX-015) that lacks the E1B-55k
gene product is the first conditionally replicating adenovirus
tested in humans to treat cancer [25]. This mutant virus was
reported in 1987 [26] and from 1996 was developed as an
anti-cancer agent in clinical trials in the United States [27].
The dl1520 virus was originally thought to selectively repli-
cate in and lyse p53-deficient cancer cells. However, increas-
ing evidence revealed that the precise role of p53 in
determining dl1520 replication selectivity was unclear [28–
31]. Current evidence suggests that both p53 inactivation
and preferential viral late RNA export, which has been
proposed to determine the tumour selectivity of the E1B-
55k-deleted oncolytic adenovirus, are associated with
E1B-55k-mediated ubiquitination [9, 32, 33]. A system-wide
comparison of protein abundance in wild-type adenovirus-
and dl1520-infected human cells should provide greater
information on how E1B-55k affects the host cell.
Quantitative tandem mass spectrometry (MS/MS)-based
proteomics is widely used to identify and quantify a large
number of proteins in a high-throughput manner. Tandem
mass tagging (TMT) of peptide samples enables multiplex
relative quantitation by mass spectrometry (MS). This
approach has been utilized to identity a large number of
proteins and quantitate the relative abundance of proteins
in response to stimuli [34, 35]. In this study, we used this
technique to identify proteins that are depleted in wild-type
adenovirus-infected cells and/or dl1520-infected cells.
We have previously published a dataset of quantitative pro-
teomics to identify proteins that may be subjected to
degradation by wild-type adenovirus [36]. This study repre-
sents a more focused analysis of the role of E1B-55k in
virally mediated degradation of cellular proteins, as this pro-
tein and its effects on cellular protein degradation have been
widely studied. We analysed protein abundance changes in
A549 cells during wild-type or dl1520 virus infection using
time-course proteomics. This study provides the first global
analysis of E1B-55k-associated protein expression changes
in human carcinoma cells. Moreover, we validated E1B-
55k-mediated degradation of more novel proteins in
adenovirus-infected cells, and identified those early-region
adenovirus proteins that contribute to their degradation.
Thus, we showed that quantitative proteomic analysis of
virally infected cells is effective at identifying novel targets
of specific virally induced degradation. Moreover, the data-
set provides insights into the abundance changes of almost
5900 cellular proteins that occur during wild-type adenovi-
rus or dl1520 infection. This should serve as a useful
resource, potentially leading to a greater understanding of
the role of E1B-55k during infection.
RESULTS
Comparative proteome analysis of wild-type, and
E1B-55k-deletion, adenovirus-infected cells
To gain a comprehensive overview of the whole-cell protein
expression in response to infection by wild-type human
adenovirus type 5 (Ad5) or E1B-55k-deleted adenovirus
(dl1520), we exploited 10-plex TMT quantitation to com-
pare relative protein abundance over a time course. As
A549 cells are highly permissive for both Ad5 and dl1520
adenovirus infection [29], we used A549 cells as the host
cells in this study. We first examined the accumulation of
viral early and viral late proteins in A549 cells, as a function
of time of infection. The results of the preliminary experi-
ments were used to design a time series that covered the
virus infectious cycle, while focusing on the period (6–24 h
after infection) in which the synthesis of viral macromole-
cules and changes in viral protein expression were maximal.
Western blot analysis showed that the viral-early E2A DBP
and E1B-55k proteins were expressed at 12 h post-infection
(h p.i.) (Fig. 1a, b), while the viral-late protein VI (pVI) was
produced at 18 h p.i. (Fig. 1b).
At four time points following Ad5 or dl1520 infection (6,
12, 18 and 24 h) with uninfected cells (0 h), Ad5- and
dl1520-virus-infected A549 cells were harvested, and cells
from the nine experiments were processed as described in
the Methods section for quantitative proteomic analyses.
The raw data files were processed and quantified using Pro-
teome Discoverer software. At a false discovery rate (FDR)
of 1%, this analysis identified 8190 proteins (Table S1, avail-
able in the online Supplementary Material). For further pro-
teome analysis, the protein abundance ratio was represented
for wild-type or dl1520 adenovirus-infected cells compared
to uninfected cells. We retained proteins identified and
quantitated by at least two peptides and with an abundance
ratio variability of less than 200%. Protein abundance ratios
are normally reported as the median value of all the ratios
from peptides quantitated and identified as belonging to the
protein in question. Allied to this, the abundance ratio vari-
ability percentage is an indicator of how divergent the
peptide ratios used to calculate a particular protein ratio are
– large percentage values indicate that individual peptides
may be reporting very different abundance ratios, which in
our experience means that the median value may be mis-
leading (Table S1). Any protein exhibiting a 2.5-fold-or-
Fu et al., Journal of General Virology 2017;98:1377–1388
1378
Downloaded from www.microbiologyresearch.org by
IP:  137.222.138.50
On: Tue, 22 Aug 2017 07:58:10
greater increase, or a 50% decrease, based on the protein
relative abundance of proteins at 24 h p.i., was flagged as
having significantly changed abundance. By this criterion,
following virus infection, more than 5300 proteins were
apparently unchanged in protein abundance, and less than
5% of identified proteins were changed in abundance
(Fig. 2a). The number of virus down-regulated proteins
gradually increased during virus infection (Fig. 2b). The
quality of the proteome-wide quantitation was demon-
strated by the consistency of the dynamic MS-based profiles
for key marker proteins (Fig. 2c, d). In line with previous
studies, MRE11 and p53, two known targets of E1B-55k/
E4orf6 E3 ubiquitin ligase, were decreased during wild-type
adenovirus infection, whilst in dl1520-infected A549 cells,
MRE11 protein levels remained unchanged and p53 protein
abundance increased significantly (Fig. 2c). Moreover, in
agreement with observations reported by research groups
[37, 38], a transient increase in p53 protein abundance early
in Ad5 infection (at 6 h p.i.) and during dl1520 infection (6–
24 h p.i.) was also determined in the MS analysis (Fig. 2c).
Adenovirus E1B-55k protein regulates expression
of cellular proteins and cellular programmes
To understand the cellular programmes regulated by the
altered proteins during Ad5 infection and dl1520 infection,
we performed biological pathway enrichment analysis using
the Reactome database [39, 40]. This revealed that the
changes induced spanned a broad range of categories (Fig. 3
and Table S2). During wide-type adenovirus (Ad5) infec-
tion, the cellular proteins most affected were associated with
chromatin organization, DNA replication and cell cycle at
6 h p.i.; with chromatin organization, DNA replication and
cellular responses to stress at 12 h p.i.; with DNA replica-
tion, cellular responses to stress and DNA repair at 18 h p.i.;
and with DNA replication, cellular responses to stress and
cell cycle at 24 h p.i. (Table S2). Compared to Ad5 infection,
during dl1520 infection there were fewer cellular proteins
affected in the early phase (Fig. 3a, b), whereas during the
late phase the number of cellular proteins affected was com-
parable to the changes seen during Ad5 infection (Fig. 3c, d)
and the cellular proteins most affected were implicated in
DNA replication and cellular responses to stress and cell
cycle (Table S2). The expression of the viral early E2A DBP
and E1B-55k proteins and the late protein VI (pVI) shown
in Fig. 1, illustrates that the two viruses were at comparable
stages in their viral replication cycles in this experiment.
Protein abundance is not exclusively regulated by
E1B-55k
We first identified those proteins that decreased signifi-
cantly during Ad5 infection: 69 proteins were shown to be
decreased more than twofold in response to Ad5 infection.
Secondly, the 69 proteins degraded during Ad5 infection
were examined to see how their abundance changed during
dl1520 infection to highlight those proteins whose degrada-
tion may be at least partly E1B-55k mediated. The results
are showed in Table 1. Among the 69 proteins, 41 exhibited
a 50% decrease in dl1520-infected A549 cells. Thus, many
cellular proteins may be degraded by adenovirus by
mechanisms independent of E1B-55k status. This is consis-
tent with a recent study showing that GTF2I degradation is
dependent upon adenovirus E4orf3 expression [22], some-
thing also reflected in this data set. We have also included
RNA-Seq data on changes to gene expression during adeno-
virus infection, which we reported in an earlier study of
adenovirus infection of HeLa cells [36]. However, changes
in gene expression as a proxy for protein expression need to
be treated cautiously, as this does not take into account
other factors that affect protein abundance, such as transla-
tion initiation, whether a protein is exported from the cell,
or the half-life of proteins.
The adenovirus early-region proteins E1B-55k,
E4orf3 and E4orf6 mediate the removal of the
cellular proteins ALCAM, EPHA2 and PTPRF
Comparing protein abundance changes between Ad5-
infected A549 cells and dl1520-infected A549 cells, our data
highlighted cellular proteins previously known to be tar-
geted by adenovirus for E1B-55k-mediated degradation,
including MRE11, RAD50 and NBN (also known as NBS1)
[7] (Table 2). We looked for additional cellular targets with
a similar pattern of degradation during Ad5 infection: that
is, a decline in protein abundance in the presence of E1B-
55k. More than ten proteins meeting this criterion were
identified, including three cell-adhesion molecules, ALCAM
(CD166), EPHA2 (Eck) and PTPRF (LAR). As cell-adhesion
0 6 12 18 24 0 6 12 18 24 h
0 6 12 18 24 6 12 18 24 h
Ad5
(a)
(b)
dl1520
Ad5 dl1520
DBP
b-Actin
E1B-55k
pVI
b-Actin
Fig. 1. Infection of A549 cells with Ad5 and dl1520. A549 cells were
infected with Ad5 and dl1520 at a multiplicity of infection (MOI) of 10
for 0, 6, 12, 18 and 24 h. The cell lysates were harvested and the pres-
ence of the viral proteins DBP (a), E1B-55k (b) and pVI (b) were moni-
tored as markers of viral infection by Western blotting. b-Actin was an
internal control.
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molecules play roles in cell detachment and promoting the
release and spread of progeny virions, they may represent
important new substrates for degradation by the E1B-55k/
E4orf6 E3 ubiquitin ligase, and therefore we decided to ana-
lyse this class of cell proteins further (Table 2).
In order to independently validate the TMT data for the
selected proteins, we performed Western blot analysis on
Ad5-infected A549 cells treated with the proteasome inhibi-
tor, MG132. The results confirmed that the protein levels of
ALCAM, EPHA2 and PTPRF declined significantly in A549
cells infected with Ad5 virus (Fig. 4a). However, only the
degradation of EPHA2 and ALCAM was sensitive to
proteasome inhibition by MG132. When cells were treated
with 20 µM MG132, EPHA2 and ALCAM the protein levels
in Ad5-infected cells remained comparable to those of
mock-infected cells, whereas, surprisingly, PTPRF levels
were decreased in MG132-treated cells, even without viral
infection. These results suggested that proteasome activity is
required for adenovirus-mediated EPHA2 and ALCAM
reduction. Since MG132 alone triggers degradation of
PTPRF protein, its virally triggered degradation pathway
remains less clear.
We next examined which early region proteins, E1B-55k,
E4orf3 and/or E4orf6, were involved in the adenovirus-
induced degradation of these target proteins, or whether an
alternative degradative pathway had occurred. We examined
the effect of wild-type or early-region gene-mutated
adenovirus [E1B-55k-(dl1520), E4orf3-(pm4150), E4orf6-
(pm4154), E4orf3-/E4orf6-(pm4155)] infection on ALCAM,
EPHA2 and PTPRF (Fig. 4b). Allied to this, we wanted to
determine if these adenovirus proteins alone could affect lev-
els of these cellular proteins by transfecting A549 cells with
plasmids expressing one or two viral early proteins (Fig. 4c).
Intriguingly, although wild-type adenovirus (wt) reliably
5455 5416 5409 5341 5689
5848 5568 5468
258 282 249 278
109 18 209 225
0
1000
2000
3000
4000
5000
6000
7000
(a) (b)
(c)
(d)
6 h 12 h 18 h 24 h 6 h 12 h 18 h 24 h
Ad5 dl1520
N
u
m
b
e
r 
o
f 
p
ro
te
in
s
Unchanging Changing
239 251
188
135
98
16
177 158
19
31
61
143
11
2
32 67
0
50
100
150
200
250
300
350
6 h 12 h 18 h 24 h 6 h 12 h 18 h 24 h
Ad5 dl1520
N
u
m
b
e
r 
o
f 
p
ro
te
in
s
Increasing Decreasing
Protein
Wild-type adenovirus:
Ad5
E1B-55k-deleted adenovirus:
d1520
6 h 12 h 18 h 24 h 6 h 12 h 18 h 24 h
MRE11 1.41 0.76 0.37 0.26 1.47 1.21 1.34 1.40
p53 2.03 0.52 0.31 N/A 0.97 3.70 9.36 12.35
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Fig. 2. TMT-based proteomic time course of protein expression in adenovirus-infected A549 cells. Ad5- and dl1520-virus-infected
A549 cells were sampled over 24 h and the relative abundance of cellular proteins was monitored by an LC-MS/MS system. We used
proteins identified by at least two peptides in this analysis. (a) Summary of the proteomics data. The number of proteins exhibiting a
change in abundance (changing) or remaining unchanged (unchanging) after Ad5 or dl1520 infection of A549 cells at all time points is
indicated. (b) The number of proteins that showed a 2.5-fold-or-greater increase (increasing) or a 50% decrease (decreasing) during
infection. (c) Temporal profiles of MRE11 and p53 obtained in the MS/MS analysis. GAPDH was an internal control. The protein abun-
dance ratio is shown for wild-type or dl1520 adenovirus-infected cells compared to uninfected cells. N/A indicates no abundance ratio
could be determined in that experiment, even though the protein was identified. (d) The cell lysates harvested at 24 h p.i. were
assessed for the presence of the cellular proteins MRE11 and p53 by Western blotting. The viral early protein E1B-55k and viral late
protein pVI were monitored as markers of adenoviral infection. b-Actin served as a loading control.
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degraded ALCAM, PTPRF and EPHA2, the pathways trig-
gering their degradation appear to be distinct and complex.
From the transfection studies, expression of E4orf6 alone, or
E1B-55k/E4orf3 or E1B-55k/E4orf6 combinations, can target
ALCAM for some degradation (Fig. 4c). A549 cells infected
with a virus lacking either E1B-55k or E4orf3 showed partial
degradation of ALCAM, but the protein levels of ALCAM in
cells infected with a virus lacking E4orf6 or E4orf3 and
E4orf6 together remained unchanged (Fig. 4b). These results
implicate E4orf6, E1B-55k/E4orf6 and E4orf3/E4orf6 in deg-
radation of ALCAM. PTPRF levels decreased in A549 cells
infected with a viral mutant that does not express E4orf3
(pm4150) or E4orf6 (pm4154), but were unaffected by E1B-
55k-deleted (dl1520) and E4orf3/E4orf6-deleted viruses
(pm4155) (Fig. 4b). The reduction of PTPRF was detected in
A549 cells expressing either E1B-55k/E4orf3 or E1B-55k–
E4orf6 (Fig. 4c) and partial degradation was observed by
those expressing E4orf6 alone (Fig. 4c). The reduction in
EPHA2 was still evident following infection with either
E4orf3-deleted virus or E4orf6-deleted virus (Fig. 4b), while
from transfection studies, E1B-55k/E4orf6 was involved in
the reduction of EPHA2 (Fig. 4c). We determined that pro-
teasome activity is required for ALCAM and EPHA2 reduc-
tion (Fig. 4a), and the effects of adenovirus infection on
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Gene expression
Metabolism
Metabolism of proteins
Signal transduction
Immune system
Cell cycle
Vesicle-mediated transport
Hemostasis
Cellular responses to stress
Transmembrane transport of small molecules
Organelle biogenesis and maintenance
Chromatin organization
DNA repair
Programmed cell death
DNA replication
Extracellular matrix organization
Number of proteins
6 h(a) (b)
(c) (d)
Ad5
dl1520
0 10 20 30 40 50 60 70
Gene expression
Metabolism
Metabolism of proteins
Signal transduction
Immune system
Cell cycle
Vesicle-mediated transport
Hemostasis
Cellular responses to stress
Transmembrane transport of small molecules
Organelle biogenesis and maintenance
Chromatin organization
DNA repair
Programmed cell death
DNA replication
Extracellular matrix organization
Number of proteins
12 h
Ad5
dl1520
0 10 20 30 40 50 60 70
Gene expression
Metabolism
Metabolism of proteins
Signal transduction
Immune system
Cell cycle
Vesicle-mediated transport
Hemostasis
Cellular responses to stress
Transmembrane transport of small molecules
Organelle biogenesis and maintenance
Chromatin organization
DNA repair
Programmed cell death
DNA replication
Extracellular matrix organization
Number of proteins
18 h
Ad5
dl1520
0 10 20 30 40 50 60
Gene expression
Metabolism
Metabolism of proteins
Signal transduction
Immune system
Cell cycle
Vesicle-mediated transport
Hemostasis
Cellular responses to stress
Transmembrane transport of small molecules
Organelle biogenesis and maintenance
Chromatin organization
DNA repair
Programmed cell death
DNA replication
Extracellular matrix organization
Number of proteins
24 h
Ad5
dl1520
Fig. 3. Biological pathway enrichment analysis using the Reactome database. Cellular proteins exhibiting changes during Ad5 infection
and during dl1520 were analysed by the Reactome database (www.reactome.org/): (a) 6 h post-infection; (b) 12 h post-infection; (c)
18 h post-infection; (d) 24 h post-infection. The number of proteins is indicated at the bottom of the figure. Ad5-regulated proteins are
shown in orange and dl1520-regulated proteins are shown in blue.
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Table 1. Proteins decreased in A549 cells infected with adenovirus
A list of proteins that decreased in abundance more than twofold in Ad5- and/or dl1520-infected A549 cells compared to uninfected A549 cells at
24 h p.i.; the data were generated in this study. Fold change in gene expression between Ad5-infected HeLa cells at 24 h p.i. and uninfected HeLa
cells; the RNA–Seq data were obtained from our previous studies [36].
UniProt accession Protein description Gene name mRNA fold change in HeLa cells
Protein decreased in amount >twofold during Ad5 infection and during dl1520 infection
A0A024RCT1 TAP binding protein (Tapasin), isoform CRA_c TAPBP 0.56
P55268 Laminin subunit beta-2 LAMB2 1.56
X5CMH5 TAP2 TAP2 3.92
Q99650 Oncostatin-M-specific receptor subunit beta OSMR 1.03
B2RMV2 CYTSA protein CYTSA 2.15
P35568 Insulin receptor substrate 1 IRS1 0.24
Q0IIN7 Nuclear receptor coactivator 3 NCOA3 0.79
P05121 Plasminogen activator inhibitor 1 SERPINE1 0.11
Q8N6N3 UPF0690 protein C1orf52 C1orf52 0.46
Q14641 Early placenta insulin-like peptide INSL4 0
B7Z168 Neuregulin 1 isoform HRG-alpha NRG1 0
Q9UK54 Haemoglobin beta subunit variant HBB Not detected
X5D2J9 General transcription factor IIi isoform D GTF2I 0.79
Q7Z5L9 Interferon regulatory factor 2-binding protein 2 IRF2BP2 0.61
P15428 15-hydroxyprostaglandin dehydrogenase [NAD(+)] HPGD 0.72
P17676 CCAAT/enhancer-binding protein beta CEBPB 0.24
H0Y485 Insulin-like growth factor-binding protein 3 IGFBP3 0.87
P40189 Interleukin-6 receptor subunit beta IL6ST 0.97
A0A087WV90 Dystrophin DMD 1.19
Q12860 Contactin-1 CNTN1 Not detected
Q8IY57 YY1-associated factor 2 YAF2 0.6
Q9NPA3 Mid1-interacting protein 1 MID1IP1 0.35
Q5MJ32 Protection of telomeres protein 1 variant 5 POT1 1.36
O00767 Acyl-CoA desaturase SCD 2.64
A2AJT9 Uncharacterized protein CXorf23 CXorf23 0
Q8IUC4 Rhophilin-2 RHPN2 0.55
Q5VUA4 Zinc finger protein 318 ZNF318 0.41
O14757 Serine/threonine-protein kinase Chk1 CHEK1 1.16
P14384 Carboxypeptidase M CPM 1.28
O43318 Mitogen-activated protein kinase kinase kinase 7 MAP3K7 0.7
P35869 Aryl hydrocarbon receptor AHR 0.29
Q8NCD3 Holliday junction recognition protein HJURP 0.11
P78545 ETS-related transcription factor Elf-3 ELF3 0.07
Q07973 1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial CYP24A1 0.18
A0A087WWW9 B-cell lymphoma/leukaemia 10 BCL10 0.31
P35354 Prostaglandin G/H synthase 2 PTGS2 0
Q59GZ8 Urokinase plasminogen activator preproprotein variant PLAUR 0.79
P63313 Thymosin beta-10 TMSB10 0.54
B2RUU3 Dedicator of cytokinesis 1 DOCK1 0.28
F5H7B7 ATP-binding cassette sub-family A member 13 ABCA13 Not detected
P62328 Thymosin beta-4 TMSB4X Not detected
Protein decreased in amount twofold during Ad5 infection and slightly decreased (1.5–2 fold) during dl1520 infection
H3BS02 [3-methyl-2-oxobutanoate dehydrogenase (lipoamide)] kinase BCKDK 1.3
Q6QWC0 TAP1 TAP1 Not detected
Q9NZV1 Cysteine-rich motor neuron 1 protein CRIM1 0.24
Q13641 Trophoblast glycoprotein TPBG 0.48
Q96L35 EPH receptor B4, isoform CRA_b EPHB4 0.51
Q96HR8 H/ACA ribonucleoprotein complex non-core subunit NAF1 NAF1 1.19
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ALCAM and EPHA2 levels (Fig. 4b, c) support the conten-
tion that at least the E1B-55k/E4orf6 complex targets
ALCAM and EPHA2 for ubiquitination and subsequent pro-
teasome-mediated degradation.
DISCUSSION
In this time-course study, global analysis of the host proteome
remodelling during adenovirus infection was performed using
a more focused approach: comparing protein abundance in
wild-type vs E1B-55k-deletion-mutant adenovirus-infected
cells. This produced a temporal map of protein abundance
changes for 5937 proteins in Ad5-infected A549 cells
compared to dl1520-infected A549 cells. Bioinformatics analy-
sis using the Reactome database revealed that the adenovirus-
regulated proteins were involved in several cellular pro-
grammes, including chromatin organization, DNA replication,
cell cycle and cellular response to stress (Fig. 3 and Table S2).
Adenovirus early-region proteins interact together to modify
critical cellular pathways and prepare the host cell for viral
replication. As a key example of this, E1B-55k, E4orf3 and
E4orf6 have been the subject of much research and there are
several well-characterized interactions between these viral pro-
teins and the host cells (reviewed in [41]). Our proteomics
data revealed some 69 cellular proteins that are degraded
Table 1. cont.
UniProt accession Protein description Gene name mRNA fold change in HeLa cells
P17275 Transcription factor jun-B JUNB 0.17
A2ACR1 Proteasome subunit beta type PSMB9 Not detected
Q9H1E3 Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 NUCKS1 1
Q96DI9 POLDIP3 protein POLDIP3 0.87
Q96BU1 S100P-binding protein S100PBP 1.36
H3BUT5 Nuclear envelope phosphatase-regulatory subunit 1 CNEP1R1 0
A0A024R4D3 Melanophilin, isoform CRA_b MLPH Not detected
Q9UMY1 Nucleolar protein 7 NOL7 1.11
Q6IE81 Protein Jade-1 JADE1 0.37
Q6MZZ4 Putative uncharacterized protein DKFZp686H0575 ELF1 0.45
Q14814 Myocyte-specific enhancer factor 2D MEF2D 0.56
Protein decreased in amount >twofold during Ad5 infection but did not decrease during dl1520 infection
B6E46 Cellular tumour antigen p53 p53 1.24
P49959 Double-strand break repair protein MRE11A MRE11A 2.16
Q92878 DNA repair protein RAD50 RAD50 2.18
Q13740 CD166 antigen ALCAM 1.36
P29317 Ephrin type-A receptor 2 EPHA2 0.41
F1T0K4 DmX-like protein 1 DMXL1 0.89
E9PMH5 Baculoviral IAP repeat-containing protein 2 BIRC2 0.49
O60934 Nibrin NBN 1.19
Q8NAF0 Zinc finger protein 579 ZNF579 0
P10586 Receptor-type tyrosine-protein phosphatase F PTPRF 4.71
Q7Z589 Protein EMSY EMSY 0.69
Table 2. Proteins decreased in A549 cells infected with Ad5, but remained unchanged during dl1520 infection
Protein name Ad5* dl1520†
6 h 12 h 18 h 24 h 6 h 12 h 18 h 24 h
MRE11A‡ 1.41 0.76 0.37 0.26 1.47 1.21 1.34 1.40
RAD50‡ 1.35 0.69 0.35 0.30 1.38 1.28 1.29 1.21
NBN‡ 1.18 1.19 0.58 0.42 1.23 1.21 1.10 0.92
ALCAM 1.11 0.77 0.52 0.47 1.07 1.20 1.37 1.14
EPHA2 1.24 1.23 0.54 0.46 1.32 1.24 1.23 1.09
PTPRF 0.79 0.85 0.59 0.43 0.82 0.81 0.74 0.73
*Protein abundance ratio is shown for wild-type adenovirus (Ad5)-infected cells compared to mock-infected cells.
†Protein abundance ratio is shown for E1B-55k-deleted adenovirus (dl1520)-infected cells compared to mock-infected cells.
‡Known cellular proteins whose levels are reduced via adenoviral E1B-55k functions.
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following adenovirus infection, but of these, E1B-55k appears
to be required for the shut-off and removal of just 11 cellular
proteins, some novel and some previously known (Table 1).
Dallaire et al. [10] identified the cell-surface molecule,
integrin a3, as a substrate of the E1B-55k-mediated E3
ligase complex and suggested that other adhesion molecules
may also be affected by E4orf6/E1B-55k. In this study, we
found that three novel cell adhesion molecules, ALCAM,
EPHA2 and PTPRF, are affected by E1B-55k, E4orf6 and/or
E4orf3, and the pathways triggering their degradation are
more complex than has previously been reported.
ALCAM protein was degraded by wild-type adenovirus
(Fig. 4b) and the analysis of infection with single or double
mutants revealed that there appear to be two or more
mechanisms promoting degradation. In the context of
transfection experiments (Fig. 4c), the degradation of
ALCAM appears to occur on the expression of E4orf6 alone,
E1B-55k/E4orf3 or E1B-55k/E4orf6. In the context of a full
virus infection, E4orf6 is required for ALCAM reduction
(Fig. 4b). In addition, removal of ALCAM is dependent on
the proteasome activity (Fig. 4a). Together, these data sug-
gest that ALCAM is a target of adenoviral E1B-55k/E4orf6
ubiquitin ligase. However, additional studies will be
required to explain in detail how adenovirus infection
modulates overall ALCAM abundance.
Nevertheless, degradation of ALCAM may be a strategy for
cell detachment and restricting immune surveillance via ade-
novirus-induced targeted ubiquitination. ALCAM, also
known as CD166, is an activated leukocyte cell-adhesion
molecule that mediates both heterotypic cell–cell contacts
and homotypic cell–cell contacts [42, 43]. In addition,
ALCAM has been identified as a bona fide target of viral pro-
tein K5, a modulator of immune recognition from Kaposi’s
sarcoma-associated herpesvirus, which prevents activation
of cytotoxic T cells and natural killer cells [44]. Potentially,
the clearance of ALCAM during infection might inhibit
Mock Ad5 Mock Ad5
+MG132–MG132
(a) (b)
(c)
EPHA2
PTPRF
E1B-55k
b-Actin
MRE11
DBP
ALCAM
+MG132–MG132
Mock Ad5 Mock Ad5
b-Actin
b-Actin
E1B-55k
E4orf6
E4orf3
PTPRF
ALCAM
p53
EPHA2
wt E1B-55k
–
E4orf3
–
E4orf6
–
0 24 48 24 48 24 48 24 48 24 48 hpi.
E4orf3
–
/
E4orf6
–
b-Actin 
E1B-55k 
E4orf6 
E4orf3 
PTPRF 
ALCAM 
p53 
EPHA2 
E1B-55k 
E4orf3 
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Fig. 4. Ad5-induced degradation of the cellular proteins ALCAM, EPHA2 and PTPRF is mediated by the adenovirus early-region pro-
teins E1B-55k, E4orf3 and/or E4orf6. (a) Effect of proteasome inhibition on ALCAM, EPHA2 and PTPRF levels. A549 cells were unin-
fected (mock) or infected with Ad5 or dl1520 at an MOI of 10. After 6 h the uninfected and adenovirus-infected cells were treated with
the proteasome inhibitor MG132 at a final concentration of 20 µM. The cells were incubated under normal conditions for a further 18 h
and then harvested. ALCAM, EPHA2, PTPRF, MRE11, E1B-55k and DBP were visualized by immunoblotting using the appropriate anti-
bodies. b-Actin served as a loading control. The left-hand part of the panel was cropped from the same gel exposure in the case of
each of the antigens shown. (b) Infection of A549 cells. A549 cells were left uninfected or infected with either Ad5 or mutant Ad5 prep-
arations at an MOI of 5. Total cell extracts were prepared 24 and 48 h p.i., and proteins were separated by SDS-PAGE and subjected to
immunoblotting using E1B-55k, E4orf3, E4orf6, p53, ALCAM, EPHA2 and PTPRF antibodies. b-Actin served as a loading control. (c)
A549 cells were transfected with plasmids expressing combinations of adenovirus E1B-55k, E4orf3 and E4orf6, as indicated. After
48 h the total cell lysate was harvested and, as before, cellular proteins were detected by Western blots with b-actin used as a
loading control.
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ALCAM-dependent immune responses and promote
adenovirus propagation.
EPHA2, also called Eck (epithelial cell kinase), is a receptor
tyrosine kinase that binds to membrane-bound ephrin-A
family ligands and functions to regulate cell migration and
cell growth [45]. Our data suggest that EPHA2 is a novel
substrate for Ad5 E1B-55k-mediated proteasomal degrada-
tion. Studies with mutant adenoviruses revealed that
EPHA2 degradation is dependent upon E1B-55k/E4orf6
expression (Fig. 4b, c). However, our data also suggest that
there might be redundant pathways involved in the E1B-
55k/E4orf3-mediated EPHA2 reduction (Fig. 4b, c).
PTPRF, also known as LAR (leukocyte common antigen
related), is a receptor-like protein tyrosine phosphatase
located in the plasma membrane. The degradation of
PTPRF appears to be dependent upon adenoviral E1B-55k/
E4orf6 or E1B-55k/E4orf3 protein expression (Fig. 4b, c).
However, as PTPRF protein levels were reduced in MG132-
treated uninfected A549 cells via an unknown mechanism
(Fig. 4a), further work is required to determine exactly how
adenovirus reduces overall levels of this protein in the cell.
Evidence from recent work indicates that PTPRF modulates
cell migration through dephosphorylating EPHA2 [46]. The
EPHA2 receptor is also known to interact with integrin a3
(a known substrate of the E1B-55k/E4orf6 E3 ubiquitin
ligase complex) in U251MG glioblastoma cells, and contrib-
utes to the crosstalk between Eph and integrin signalling
pathways at membrane protrusions [10, 47]. Taken
together, our data suggest that it is likely that adenovirus
regulates cell-surface proteins through E1B-55k, and the
relationship between adenovirus infection and cell-surface
molecules is more complex than is currently understood.
There is also a formal possibility that the reduction of pro-
tein abundance could be an indirect result of changes in
mRNA levels or it might be because adenovirus induces the
export and shedding of these cellular proteins. However, as
EPHA2 and ALCAM degradation is readily blocked by
MG132, we argue that the weight of evidence suggests that
their degradation is a post-translational effect mediated by
combinations of E1B-55k and/or E4orf6 and E4orf3. For
PTPRF, additional work is needed to understand exactly
how adenovirus mediates this change in cellular abundance.
Nevertheless, regardless of the precise mechanism, our
data significantly widen the list of cell-surface proteins
downregulated by adenovirus infection.
As pointed out in the Introduction, a number of proteins
are known to be down-regulated by adenovirus infection
(e.g. DNA ligase IV and integrin a3), but they were not
identified in this study. This reflects one of the downsides of
mass-spectrometry-based proteomics, namely that it is not
yet possible to guarantee that all proteins will be confidently
identified and quantitated.
In conclusion, we have characterized relative protein abun-
dance changes in A549 cells infected with wild-type adeno-
virus and/or E1B-55k-deleted adenovirus. From these data
we have obtained a range of novel cellular proteins targeted
by adenovirus for degradation, including the identification
of novel E1B-55k-dependent targets. This study identifies a
wider range of cellular targets for adenovirus-mediated deg-
radation and our follow-up analysis revealed that
adenovirus-mediated protein degradation may involve mul-
tiple (and potentially partially redundant) pathways. More-
over, the time-course dataset for protein abundance changes
is a valuable data resource for the study of wild-type and
E1B-55k-deleted adenoviruses.
METHODS
Cells and viruses
Human lung carcinoma cells (A549) were cultured in
Dulbecco’smodified Eagle’s medium with 4.5 g l 1 glucose
and L-glutamine (DMEM, Lonza), supplemented with 10%
fetal bovine serum (FBS), streptomycin (100 µgml 1) and
penicillin (100 IU ml 1) (Life Technologies). Wild-type
human adenovirus type 5 (Ad5) was propagated as
described previously [48] and preparations were purified
twice by caesium chloride density gradient centrifugation
[49]. The mutant human adenovirus preparations, deleted
in E1B-55k (dl1520), E4orf3 (pm4150), E4orf6 (pm4154)
and E4orf3 and E4orf6 (pm4155), have been described pre-
viously [21, 26, 50]. We thank Thomas Dobner (HPI, Ham-
burg) for kindly providing E4orf3 (pm4150), E4orf6
(pm4154) and E4orf3 and E4orf6 (pm4155)
deletion viruses.
Adenovirus infection, TMT labelling and high pH
reversed-phase chromatography
A549 cells were seeded at a concentration of 1106 cells and
left overnight to adhere. The cultures were infected with
either Ad5 or dl1520 at a multiplicity of infection (MOI) of
10. The cells were incubated under normal conditions for 0,
6, 12, 18 and 24 h, and then harvested and washed twice in
PBS. For each sample, the cell pellets were resuspended in
five-cell-pellet volumes of lysis buffer containing 8 M urea
in 50mM triethylammonium bicarbonate (TEAB) (Thermo
Scientific), pH 8, and 1 protease inhibitor cocktail (Roche,
11836170001), followed by sonication (15 s2 on ice, at
20% output). Then, the samples were spun at 17 000 g for
10min at 4 C. The protein concentration of the cell extracts
was determined using the BCA protein assay kit (Thermo
Fisher Scientific).
Aliquots of 100 µg of ten samples per experiment were
digested with trypsin (2.5 µg trypsin per 100 µg protein;
37 C, overnight) and labelled with tandem mass tag (TMT)
ten-plex reagents according to the manufacturer’s protocol
(Thermo Fisher Scientific); the labelled samples were
then pooled.
A 50 µg aliquot of the pooled sample was evaporated to dry-
ness and resuspended in buffer A (20mM ammonium
hydroxide, pH 10) prior to fractionation by high-pH
reversed-phase chromatography using an Ultimate 3000
liquid chromatography system (Thermo Fisher Scientific).
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In brief, the sample was loaded onto an XBridge BEH C18
column (130Å, 3.5 µm, 2.1150mm; Waters, UK) in buffer
A and the peptides were eluted with an increasing gradient
of buffer B (20mM ammonium hydroxide in acetonitrile,
pH 10) from 0–95% over 60min. The resulting fractions
were evaporated to dryness and resuspended in 1% formic
acid prior to analysis by nano-LC MS/MS using an Orbitrap
Fusion Tribrid mass spectrometer (Thermo Scientific).
Nano-LC mass spectrometry
High-pH RP fractions were further fractionated using an
Ultimate 3000 nano HPLC system in line with an Orbitrap
Fusion Tribrid mass spectrometer (Thermo Scientific). In
brief, peptides in 1% (vol/vol) formic acid were injected
onto an Acclaim PepMap C18 nano-trap column (Thermo
Scientific). After washing with 0.5% (vol/vol) acetonitrile
0.1% (vol/vol), formic acid peptides were resolved on a
250mm75 µm Acclaim PepMap C18 reverse-phase ana-
lytical column (Thermo Scientific) over a 150min organic
gradient, using seven gradient segments (1–6% solvent B
over 1min, 6–15% B over 58min, 15–32% B over 58min,
32–40% B over 5min, 40–90% B over 1min, held at 90% B
for 6min and then reduced to 1% B over 1min) with a flow
rate of 300 nl min 1. Solvent A was 0.1% formic acid and
solvent B was aqueous 80% acetonitrile in 0.1% formic
acid. Peptides were ionized by nano-electrospray ionization
at 2.0 kV using a stainless steel emitter with an internal
diameter of 30 µm (Thermo Scientific) and a capillary tem-
perature of 275 C.
All spectra were acquired using an Orbitrap Fusion Tribrid
mass spectrometer controlled by Xcalibur 1.9 software
(Thermo Scientific) and operated in data-dependent acqui-
sition mode using an SPS-MS3 workflow. FTMS1 spectra
were collected at a resolution of 120 000, with an automatic
gain control (AGC) target of 200 000 and a max injection
time of 50ms. The top N most intense ions were selected for
MS/MS. Precursors were filtered according to charge state
(to include charge states 2–7) and with monoisotopic pre-
cursor selection. Previously interrogated precursors were
excluded using a dynamic window (40s+/ 10 p.p.m.). The
MS2 precursors were isolated with a quadrupole mass filter
set to a width of 1.2 m/z. ITMS2 spectra were collected with
an AGC target of 5000, a max injection time of 70ms and a
CID collision energy of 35%.
For FTMS3 analysis, the Orbitrap was operated at 60 000
resolution with an AGC target of 50 000 and a max injection
time of 120ms. Precursors were fragmented by high-energy
collision dissociation (HCD) at a normalized collision
energy of 55% to ensure maximal TMT reporter ion yield.
Synchronous precursor selection (SPS) was enabled to
include up to fiveMS2 fragment ions in the FTMS3 scan.
Data analysis
The raw data files were processed and quantified using
Proteome Discoverer software v1.4 (Thermo Scientific) and
searched against a combined database consisting of the
UniProt human database (downloaded 8 November
2014 : 126 385 entries) and adenovirus protein sequences
using the SEQUEST algorithm. Peptide precursor mass
tolerance was set at 10 ppm and MS/MS tolerance was set
at 0.6 Da. Search criteria included oxidation of methionine
(+15.9949) as a variable modification and carbamidome-
thylation of cysteine (+57.0214) and the addition of the
TMT (+229.163) to peptide N-termini and lysine as fixed
modifications. Searches were performed with full tryptic
digestion and a maximum of one missed cleavage was
allowed. The reverse database search option was enabled
and all peptide data were filtered to satisfy a false discovery
rate (FDR) of 1%.
Infection of human A549 cells with Ad5 and mutant
virus and treatment with MG132
A549 cells were seeded at a concentration of 2105 cells per
well in a six-well plate and left overnight to adhere. The cul-
tures were either uninfected, or infected with either Ad5 or
dl1520 preps at an MOI of 10. After 6 h the uninfected and
adenovirus-infected cells were treated with the proteasome
inhibitor MG132 at a final concentration of 20 µM. The cells
were incubated under normal conditions for a further 18 h
and then harvested and washed twice in PBS. The cells were
resuspended in PBS and SDS loading buffer containing
10mM 2-mercaptoethanol and sonicated five times to
ensure complete the extraction of total cellular proteins.
Transfection of A549 cells
A549 cells were seeded at 5105 cells on 6 cm dishes. Four
hours after plating, the cells were washed twice in Optimem
(Life Technologies) and incubated with different combina-
tions of pcDNA3, pcDNA3-Ad5-E1B-55k, pcDNA3-Ad5-
E4orf3 and pcDNA3-Ad5-E4orf6 (see Fig. 4c legend) for
6 h, in the presence of Lipofectamine 2000 (Life Technolo-
gies), according to manufacturer’s recommendations. After
transfection, cells were washed once in DMEM medium
and incubated for an additional 24 h in DMEM before being
washed twice in PBS and harvested and processed for subse-
quent analysis of cellular proteins by SDS-PAGE.
Western blotting and antibodies
Test samples were first denatured by heating at 95 C for 10
min and then separated by electrophoresis on a Tris-glycine
polyacrylamide gel. Proteins were transferred to Hybond-P
PVDF membrane (GE Healthcare, UK) and probed with a
specific primary antibody, followed by a horseradish
peroxidase (HRP)-conjugated secondary antibody. Blots
were developed with the ECL detection system (GE Health-
care, UK). The primary antibodies used were monoclonal
anti-DBP [48], mouse anti-E1B-55k [51], rabbit anti-pVI
[48], polyclonal goat anti-MRE11, monoclonal mouse anti-
p53 (Santa Cruz), polyclonal rabbit anti-ALCAM (Sino Bio-
technology), polyclonal rabbit anti-b-actin (Cell Signaling),
monoclonal mouse anti-Eck/EphA2 (Merck Millipore) and
monoclonal mouse anti-LAR/PTPRF (BD Biosciences).
Anti-E4orf3 and anti-E4orf6 antibodies were provided by
Thomas Dobner (HPI, Hamburg). The secondary
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antibodies used were goat anti-rabbit IgG-HRP, goat anti-
mouse IgG-HRP and donkey anti-goat IgG-HRP
(Santa Cruz).
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